Raloxifene hydrochloride
- Product NDC
- 50228-306
- Requested package NDC
- 50228-306-20
- 11-digit product format
- 502280306
- Labeler code
- 50228
- Product ID
- 50228-306_f1da5bd3-72c2-15ff-e053-2995a90a89db
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Raloxifene hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- ScieGen Pharmaceuticals Inc
- Application
- ANDA206384
- Marketing category
- ANDA
- Marketing start
- 2016-10-12
- Substance
- RALOXIFENE HYDROCHLORIDE
- Active strength
- 60 mg/1
- Pharmacologic classes
- Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A206384-001 | RALOXIFENE HYDROCHLORIDE | RALOXIFENE HYDROCHLORIDE | 60MG | TABLET / ORAL | AB | 2016-10-12 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A206384-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A206384-001 | RALOXIFENE HYDROCHLORIDE | 60MG | TABLET / ORAL | AB | 2016-10-12 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A206384-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Raloxifene hydrochloride | RALOXIFENE HYDROCHLORIDE | Major Pharmaceuticals | e2967d3c-238c-40cf-b3d8-89482a502928 | 2025-03-28 | Boxed warning, Warnings, Adverse reactions | 206384 ANDA206384 |
| Raloxifene hydrochloride | RALOXIFENE HYDROCHLORIDE | Bryant Ranch Prepack | ad3ef791-ac90-4f66-8da6-95b31e4c3eb6 | 2023-03-30 | Boxed warning, Warnings, Adverse reactions | 206384 ANDA206384 |
| Raloxifene hydrochloride | RALOXIFENE HYDROCHLORIDE | ScieGen Pharmaceuticals Inc | 8152e68b-61a8-4897-8e03-900135b1dbd5 | 2023-01-09 | Boxed warning, Warnings, Adverse reactions | 206384 ANDA206384 50228-306-20 50228-306 50228030620 |
| Raloxifene hydrochloride | RALOXIFENE HYDROCHLORIDE | Dr.Reddys Laboratories Inc | 8f24455c-34dc-4e07-bcd3-24326b9cc377 | 2022-12-23 | Boxed warning, Warnings, Adverse reactions | 206384 ANDA206384 |
| Raloxifene hydrochloride | RALOXIFENE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 6fd63a06-5bc5-4c50-9b85-b09c89100b80 | 2018-04-27 | Boxed warning, Warnings, Adverse reactions | 206384 ANDA206384 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Raloxifene hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| RALOXIFENE HYDROCHLORIDE | 60 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4F86W47BR6 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1490065 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 8152e68b-61a8-4897-8e03-900135b1dbd5 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 7ad62b49-6132-2a8c-4edd-73f39b2bf45c | Product name | 6 | 20210312 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50228-306-20 | Raloxifene hydrochloride | 2000 in 1 BOTTLE | TABLET, FILM COATED | 2000 | 3 | |
| 50228-306-30 | Raloxifene hydrochloride | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1490065 | raloxifene HCl 60 MG Oral Tablet | PSN | 8152e68b-61a8-4897-8e03-900135b1dbd5 | 3 |
| 1490065 | raloxifene hydrochloride 60 MG Oral Tablet | SCD | 8152e68b-61a8-4897-8e03-900135b1dbd5 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 50228-306-20 | 50228030620 | 2000 TABLET, FILM COATED in 1 BOTTLE (50228-306-20) | 2016-10-12 | 0000-00-00 | No | No | Current |